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Objective:  Fibromyalgia (FM) is a debilitating pain disorder that affects 2% of the population.  
Many of the drugs prescribed to fibromyalgia sufferers are highly addictive, have limited clinical 
efficacy, and do not treat the cognitive symptoms of fibromyalgia.  The neurobiological 
substrates of fibromyalgia are unknown, but there is evidence for involvement of altered 
dopaminergic transmission in pain disorders.  Given that dopamine is  essential for proper 
cognitive function, it is possible that fibromyalgia symptoms are partly mediated by abnormal 
dopaminergic functioning.  However, the in vivo dopamine system in fibromyalgia patients has 
not been assessed.  Thus, the objective of the current study was to ascertain how the dopamine 
system in fibromyalgia differs from healthy controls.  Methods:  [18F]-Fallypride (FAL) PET 
scanning was used to assess DA changes during a working memory task relative to a baseline 
task.  Twelve patients with FM and twelve controls completed study procedures.  Subjects 
received one FAL PET scan during a 2-back working-memory condition and one during a 0-
back (attentional control) task.  Results:  Fibromyalgia subjects had higher baseline FAL 
binding potential (BPND) in the right amygdala and ventral pallidum relative to controls.  FM 
subjects had lower baseline FAL BPND in frontal, temporal, and cingulate cortices.  Voxel-wise 
paired t-tests were used to infer increases or decreases in FAL BPND (indicative of decreases or 
increases in dopamine, respectively) during 2-back performance.  Fibromyalgia subjects had 
significant dopamine release in the ACC, left insula, OFC, and bilateral hippocampus during the 
2-back task.  Conversely, decreases in DA were detected in the posterior parietal cortex and 
vmPFC.  In controls, dopamine appeared to decrease in the posterior parietal lobe, left 
hippocampus, and vmPFC during the 2-back task.  No significant DA release was detected in 
controls.  Self-reported pain ratings in fibromyalgia subjects were significantly associated with 
baseline FAL BPND in the ACC, bilateral ventral pallidum, amygdalae, and PAG.  Conclusion: 
These data suggest that in fibromyalgia, abnormalities in dopamine function may be associated 
with both working memory and pain perception.  Further studies are needed to further explore 
the potential associations between dopamine and cognitive performance and pain perception in 
FM.   
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